Home > Publications Database > Gantenerumab in Dominantly Inherited Alzheimer Disease-Reply. > print

001     276094
005     20250126000541.0
024 7 _ |a 10.1001/jamaneurol.2024.3828
|2 doi
024 7 _ |a pmid:39527036
|2 pmid
024 7 _ |a 2168-6149
|2 ISSN
024 7 _ |a 0003-9942
|2 ISSN
024 7 _ |a 0375-8540
|2 ISSN
024 7 _ |a 1538-3687
|2 ISSN
024 7 _ |a 2168-6157
|2 ISSN
024 7 _ |a 2330-9644
|2 ISSN
024 7 _ |a altmetric:170981134
|2 altmetric
037 _ _ |a DZNE-2025-00175
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Wagemann, Olivia
|0 P:(DE-2719)9001249
|b 0
|e First author
|u dzne
245 _ _ |a Gantenerumab in Dominantly Inherited Alzheimer Disease-Reply.
260 _ _ |a Chicago, Ill.
|c 2025
|b American Medical Association
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737454707_5211
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a McDade, Eric
|b 1
700 1 _ |a Bateman, Randall J
|b 2
773 _ _ |a 10.1001/jamaneurol.2024.3828
|g Vol. 82, no. 1, p. 111 -
|0 PERI:(DE-600)2701924-X
|n 1
|p 111
|t JAMA neurology
|v 82
|y 2025
|x 2168-6149
787 0 _ |a Wagemann, Olivia et.al.
|d Chicago, Ill. : American Medical Association, 2024
|i RelatedTo
|0 DZNE-2024-00567
|r
|t Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
909 C O |o oai:pub.dzne.de:276094
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9001249
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JAMA NEUROL : 2022
|d 2024-12-27
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b JAMA NEUROL : 2022
|d 2024-12-27
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21